Characterization of the Glucagonlike Peptide-1 Receptor in Male Mouse Brain Using a Novel Antibody and In Situ Hybridization
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Glucagonlike peptide 1 (GLP-1) is a physiological regulator of appetite, and long-acting GLP-1 receptor (GLP-1R) agonists lower food intake and body weight in both human and animal studies. The effects are mediated through brain GLP-1Rs, and several brain nuclei expressing the GLP-1R may be involved. To date, the mapping of the complete location of GLP-1R protein in the brain has been challenged by lack of good antibodies and the discrepancy between mRNA and protein, especially relevant in neuronal axonal processes. Here, we present a specific monoclonal GLP-1R antibody for immunohistochemistry with murine tissue and show detailed distribution of GLP-1R expression, as well as mapping of GLP-1R mRNA by nonradioactive in situ hybridization. Semiautomated image analysis was performed to map the GLP-1R distribution to atlas plates from the Allen Institute for Brain Science. The GLP-1R was abundantly expressed in numerous regions, including the septal nucleus, hypothalamus, and brain stem. GLP-1R protein expression was also observed on neuronal projections in brain regions devoid of any mRNA that has not been observed in earlier reports. Taken together, these findings provide knowledge on GLP-1R expression in neuronal cell bodies and neuronal projections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“We also detected the expression of GLP-1Rs in the DMH of GLP-1R–tdTomato reporter mice (Fig. 1H) (19, 20).”
From GLP-1 increases preingestive satiation via hypothalamic circuits in mice and humans (2024) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-wide atlas of gene expression in the adult mouse brain
Lein, E. S., Hawrylycz, M. J., Ao, N., Ayres, M., Bensinger, A., Bernard, A., Boe, A. F., Boguski, M. S., Brockway, K. S., Byrnes, E. J., et al. (2007) · Nature · doi:10.1038/nature05453 · Cited by 5,572 · cited 2×
“The GLP-1R distribution was mapped by image segmentation following semiautomatic registration of the scanned histological slides to digital atlas plates from the Allen Institute for Brain Science (AIBS) mouse brain reference model (16, 17).”
MethodElastix: a toolbox for intensity-based medical image registration
Klein, S., Staring, M., Murphy, K., Viergever, M. A., & Pluim, J. (2010) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2009.2035616 · Cited by 4,311 · cited 1×
“All registrations were computed using Elastix (21).”
On the Dependency of Cellular Protein Levels on mRNA Abundance
Liu, Y., Beyer, A., & Aebersold, R. (2016) · Cell · doi:10.1016/j.cell.2016.03.014 · Cited by 3,221
A mesoscale connectome of the mouse brain
Oh, S. W., Harris, J. A., Ng, L., Winslow, B., Cain, N., Mihalas, S., Wang, Q., Lau, C., Kuan, L., Henry, A. M., et al. (2014) · Nature · doi:10.1038/nature13186 · Cited by 2,612 · cited 2×
“The GLP-1R distribution was mapped by image segmentation following semiautomatic registration of the scanned histological slides to digital atlas plates from the Allen Institute for Brain Science (AIBS) mouse brain reference model (16, 17).”
Method(2012) · doi:10.1016/j.jmoldx.2011.08.002 · Cited by 2,567 · cited 1×
“ISH was performed using the RNAscope platform (19, 20) on neighboring sections to the sections used for whole brain IHC mapping.”
MethodThe three-dimensional organization of the hippocampal formation: A review of anatomical data
Amaral, D. G., & Witter, M. P. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90424-7 · Cited by 2,180
A role for glucagon-like peptide-1 in the central regulation of feeding
Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950 · cited 1×
“have a role in central regulating of feeding in rat and human GLP-1–activated brain areas known to regulate food intake (1).”
BackgroundADULT NEUROGENESIS IN THE MAMMALIAN CENTRAL NERVOUS SYSTEM
Ming, G.-L., & Song, H. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.051804.101459 · Cited by 1,839
Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus
Cameron, H. A., & Mckay, R. D. G. (2001) · Journal of Comparative Neurology · doi:10.1002/cne.1040 · Cited by 1,585
Zander, M., Madsbad, S., Madsen, J. L., & Holst, J. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07952-7 · Cited by 1,297 · cited 4×
“668 Jensen et al Glucagonlike Peptide 1 Receptor Characterization Endocrinology, February 2018, 159(2):665–675”
BackgroundInfluential
Research works printed but not linked: 1
- McClean P.L, Parthsarathy V, Faivre E, Hölscher C. The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease. Journal of Neuroscience, 2011;31(17):6587-6594. doi:10.1523/JNEUROSCI.0529-11.2011. · DOI · Paper page
Cited by
Items 101–152 of 152
Leziak, A., Kochman, K., & Kocełak, P. (2026) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2026.03.008 · Cited by 9
Zhang, Y., Liu, T., Guo, H., Shi, J., Yang, J., Fu, S., Pan, X., Li, F., Zhang, H., Zhang, D., et al. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000002438 · Cited by 11
“For GLP-1R detection in mouse pancreatic islets and lungs, a monoclonal antibody (Mab 7F38) described by Jensen et al was used [ 27 ] The immunohistochemistry (IHC) staining for cleaved-Caspase-1 and cleaved-Caspase-3 in lung grafts was performed as described previously [ 5 ] .”
Wilbs, J., Raavé, R., Boswinkel, M., Glendorf, T., Rodriguez, D. J., Fernandes, E. F. A., Heskamp, S., Bjørnsdottir, I., & Gustafsson, M. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c02073 · Cited by 7
“48,49 − 52 Notably, semaglutide did not cross the blood-brain barrier but interacted with the brain through the circumventricular organs.”
BackgroundMermet, M., Denom, J., Mieczkowska, A., Wery, M., Biggs, E. K., Gribble, F. M., Reimann, F., Magnan, C., Cruciani‐Guglielmacci, C., & Mabilleau, G. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00086.2025 · Cited by 8
Aguggia, J. P., Fernández, G., Cassano, D., Mustafá, E. R., Rodríguez, S., Cantel, S., Fehrentz, J., Raingo, J., Schiöth, H. B., Habib, A. M., et al. (2024) · Endocrinology · doi:10.1210/endocr/bqae160 · Cited by 6
Wulff, B. S., Kuhre, R. E., Selvaraj, M., Rehfeld, J. F., Niss, K., Fels, J. J., Secher, A., Raun, K., & Gerstenberg, M. K. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32009 · Cited by 6
Self-citationTheranostic in GLP-1R molecular imaging: challenges and emerging opportunities
Xie, Y., Wang, Y., Pei, W., & Chen, Y. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1210347 · Cited by 6
Chang, S. E., Turner, C. A., Pagan, N. M., Pereira, D., Kleer, S. I., & Flagel, S. B. (2026) · Psychopharmacology · doi:10.1007/s00213-026-07045-4 · Cited by 5
Monitoring longitudinal disease progression in a novel murine Kit tumor model using high-field MRI
Kraiger, M., Klein‐Rodewald, T., Rathkolb, B., Calzada‐Wack, J., Sanz‐Moreno, A., Fuchs, H., Wolf, E., Gailus‐Durner, V., & de Angelis, M. H. (2022) · Scientific Reports · doi:10.1038/s41598-022-17880-y · Cited by 5
Evans, B., Acharya, N., Brandl, C. G., Shealy, E., Nyland, J. E., Freet, C. S., Bunce, S. C., & Grigson, P. S. (2026) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000880 · Cited by 4
Exendin-4 increases the firing activity of hippocampal CA1 neurons through TRPC4/5 channels
Sun, H.-Z., Shen, F.-S., Li, X.-X., Liu, C., Xue, Y., Han, X., Chen, X., & Chen, L. (2023) · Neuroscience Research · doi:10.1016/j.neures.2023.08.001 · Cited by 4
“In mouse hippocampus, Jensen et al. reported rather high levels of GLP-1 receptor-immunoreactivity (Jensen et al., 2018).”
BackgroundGut-derived peptide hormone receptor expression in the developing mouse hypothalamus
Cantacorps, L., Coull, B. M., Falck, J. E., Ritter, K., & Lippert, R. N. (2023) · PLoS ONE · doi:10.1371/journal.pone.0290043 · Cited by 4
Cerroni, C., Steiner, A., Seanez, L., Kwon, S., & Lewis, A. S. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137299 · Cited by 4
Cassano, D., Aguggia, J. P., Giovanini, L., Heredia, F., Francesco, P. N. D., Andreoli, M. F., Schöth, H. B., Habib, A. M., Fernández, G., & Perelló, M. (2025) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2025.112627 · Cited by 3
Zimmermann, T., Bleymehl, K., Haebel, P., Perens, J., Roostalu, U., Hecksher‐Sørensen, J., Doerr, J., Jarosch, S., Lam, D. D., Klein, H., et al. (2026) · Molecular Metabolism · doi:10.1016/j.molmet.2026.102326 · Cited by 5
“GLP-1R is detected in substantia nigra (SNC), ventral tegmental area (VTA), amygdala, nucleus accumbens (ACB), hippocampus, several regions of the hypothalamus (paraventricular nucleus of the hypothalamus (PVH), ARH), and a multitude of caudal brainstem nuclei [18,19].”
Glucagon‐Like Peptide‐1 Receptor Agonists in Obesity‐Induced Respiratory Pathophysiology
Ruiz, M. A., Furquim, T. H. D. C., Davaanyam, D., Williams, N. R., Polotsky, V. Y., & Amorim, M. R. (2026) · Acta Physiologica · doi:10.1111/apha.70171 · Cited by 3
“GLP1R are expressed in several respiratory regions, including the parabrachial nuclei (PBN) in the pons, which shape post-inspiratory motor output, and the nucleus of solitary tract (NTS) [9].”
Automated ISH for Validated Histological Mapping of Lowly Expressed Genes
Pyke, C. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0623-0_14 · Cited by 3
Self-citationEffects of chronic ethanol consumption on brain GLP-1R gene expression in mice and humans
Torregrosa, A. B., García‐Gutiérrez, M. S., Ortuño‐Miquel, S., & Manzanares, J. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-03838-5 · Cited by 2
Tudosie, A. C., Marin, L.-M., Popa, S. G., & Golli, A. L. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27083628 · Cited by 2
GLP-1 and Parkinson’s Disease: A Comprehensive Review of Biology, Mechanisms and Efficacy
Mezabrovschi, R., Gegg, M. E., & Schapira, A. H. V. (2026) · Cells · doi:10.3390/cells15090804 · Cited by 3
Exercise modulates food reward: neurobiological mechanisms and implications for weight management
Qiu, J., Ji, P., Dai, X., Qiu, D., Fang, Q., Li, Y., Che, T., Qiu, F., & Zhang, S. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1845848 · Cited by 2
“These effects may involve the nucleus tractus solitarius, arcuate nucleus, and lateral septal nucleus, all of which are implicated in dopamine transmission and reward-related behavior (88, 89).”
The central amygdala gates exogenous glucagon-like peptide 1 signals
Duran, M., Zeng, N., Cutts, E. J., POLAMARASETTY, A., Rodríguez, M., Habegger, K. M., & Hardaway, J. A. (2026) · Molecular Metabolism · doi:10.1016/j.molmet.2026.102403 · Cited by 2
Neuroprotective Properties of Peptides
Erbaş, O., Altuntaş, İ., Nesil, P., Sasanı, H., & Odabaşı, M. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.109967 · Cited by 2
GLP-1 enhances hyperpolarization-activated currents of mouse cerebellar Purkinje cell in vitro
Liu, Y., Cao, L.-X., Wang, W., Piao, Y.-R., Wang, J.-Y., Chu, C., Bing, Y.-H., & Qiu, D. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1126447 · Cited by 3
“GLP1 receptor is a G-protein-coupled receptor that is widely expressed in the paraventricular nucleus, arcuate nucleus, ventral tegmental area, nucleus tractus solitaries, and cerebellum (Campos et al., 1994; Dunphy et al., 1998; Pyke et al., 2014; Cork et al., 2015; Heppner and Perez-Tilve, 2015; Jensen et al., 2018).”
BackgroundBurr, E. F., Roytman, M., Poirier, É., Kolbuszewska, M. T., Pfaus, J. G., Komisaruk, B. R., Goldstein, I., & Rubin, R. S. (2025) · Sexual Medicine · doi:10.1093/sexmed/qfaf073 · Cited by 3
Netsyk, O., Korol, S. V., Birnir, B., & Jin, Z. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1638550 · Cited by 4
Lachance, A., Daoust, J., Pelletier, M., Caron, A., Carpentier, A. C., Biertho, L. D., Maranzano, J., Tchernof, A., Dadar, M., & Michaud, A. (2025) · Imaging Neuroscience · doi:10.1162/imag.a.970 · Cited by 2
“…process of the hypothalamus, as they exert their effects by binding to receptors within the hypothalamus ( Al Massadi et al., 2017; Farr et al., 2016; Jensen et al., 2018; Karra et al., 2009; Li et al., 2023) or by acting on neurons projecting into hypothalamic nuclei ( Biddinger et al., 2020).”
Knackstedt, L. A. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106257 · Cited by 1
Activation of GLP-1 receptors suppresses pathological defensive aggression via DMPAG in mice
Liu, Y., Liu, X., Yin, X., Li, Y., Yu, X., Nan, X., Xue, J., Lu, H., Li, B., Zhou, F., et al. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-04385-9 · Cited by 1
Generation and use of new tools for the characterisation of gut hormone receptors
Biggs, E. K. (2018) · Apollo (University of Cambridge) · doi:10.17863/cam.37487
Glucagon‐Like Peptide‐1 Receptor Activators
Wagner, M., Evers, A., Bossart, M., & Konkar, A. A. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc268
Sexton, P. M. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737509212.793574968
Le, T. D. V., Liu, D., Besing, G.-L. K., Raghavan, R., Ellis, B. J., Ceddia, R. P., Collins, S., & Ayala, J. E. (2023) · eLife · doi:10.7554/elife.80944.sa2
Clark, M. (2023) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Ραάτ, Α. Α., & Ραάτ, Α. Α. (2024) · University of Thessaly Institutional Repository (University of Thessaly) · doi:10.26253/heal.uth.40414
De Bray, A. Y. (2025) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-gpg5vjayz
Kristensen, J. B., Nøhr-Meldgaard, J., Pors, S. E., Norlin, J., Veidal, S. S., Bendtsen, K. M., Niss, K., Andersen, M. W., Harder, L. M., Dalhoff, M. T., et al. (2026) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00011.2026 · Cited by 1
Self-citationGLP-1 agonism alters local field potential in the lateral septum and alters operant behavior in ratsPreprint
Culshaw, I. R., Jones, O. D., Ward, R. D., & Munn, R. G. K. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.19.719508
Ritchey, C. R., Peterson, B., Peters, J. H., & Rossi, D. J. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.110993
Egorova, A. V., Ryabova, M. S., Воронков, Д. Н., Stavrovskaya, A. V., Ippolitova, E., Александрович, П. И., Baranich, T. I., & Sukhorukov, V. S. (2025) · Biological Communications · doi:10.21638/spbu03.2025.402
Peptide hormone-based combinational pharmacotherapies for chronic metabolic diseases
Chui, Z. S. W., Xue, Y., Wu, X., & Xu, A. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100150
The gut, conductor of our health: putting the microbiota in the spotlight, a symposium report
Suzuki, K., Vidra, N., Kajita, C., & Pot, B. (2026) · Gut Microbiome · doi:10.1017/gmb.2026.10027
“Years later, mice were shown to express GLP-1 receptors in brain regions relevant to satiety and appetite regulation (Jensen et al., 2018).”
Pirmoradian, P., Karimi, E., Namin, S. M., Bahrami, A., Darouei, B., Amani‐Beni, R., Ebrahimi, P., Rezasoltani, M., Namazi, M. J., Hashemian, S. M. R., et al. (2026) · European journal of medical research · doi:10.1186/s40001-026-04867-y
Wittmann, G., Kádár, A., Mohácsik, P., Rasch, M. G., Ruska, Y., Várkonyi, I. Z., Dorogházi, B., Horváth, A., Liposits, Z., Gereben, B., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.10.743428
Self-citationJin, C. A., Many, G. M., Spurrier, C. S. R., Borsellino, P., Wheeler, M. T., Adkins, J., Snyder, M. P., Newgard, C. B., Radom‐Aizik, S., Cooper, D. M., et al. (2026) · Physiological Genomics · doi:10.1152/physiolgenomics.00171.2026
Tamrakar, S., Pe, L. S., Panmanee, J., Yang, J., & Mukda, S. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119946
Wang, Z., Xue, S., Zhou, X., Yuan, M., & Sun, X. (2026) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2026.2747225
Lei, S., Oraegbuna, C., & Griggs, S. L. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.7602482
Cassano, D., Fernández, G., Cornejo, M. P., Sheybani-Deloui, S., Aguggia, J. P., Cantel, S., Fehrentz, J., Habib, A. M., Rolland, L., Ravier, M. A., et al. (2026) · Life Sciences · doi:10.1016/j.lfs.2026.124754
Palmisano, M., Mrizak, H., Gonzalez, A. E., Onge, C. M. S., Erikson, C. M., Cruz, B., Flores‐Bonilla, A., Vlkolinský, R., Sharlai, O., Benedict, J., et al. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.111240
Beyond appetite: GLP-1 receptor drugs at the crossroads of pain, opioid reward, and overdose risk
Albert, O. M. (2026) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253261502914
Metadata
- Authors
- Jensen, C. B., Pyke, C., Rasch, M. G., Dahl, A. B., Knudsen, L. B., & Secher, A.
- Affiliations
- Novo Nordisk (Denmark) (DK)
- Technical University of Denmark (DK)
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2017-10-30
- Volume
- 159
- Issue
- 2
- Pages
- 665-675
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2766706007
- Cited by
- 145
- References
- 44
- Citations by year
- 2026: 22 · 2025: 19 · 2024: 14 · 2023: 23 · 2022: 17 · 2021: 21 · 2020: 17 · 2019: 9 · 2018: 3
- FWCI
- 4.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion, other-oa)
- Funders
- Novo Nordisk
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- GLP-1 receptor, brain receptor distribution, monoclonal antibodies, mRNA-protein correlation, neuronal projections, hypothalamus, septal nuclei, brainstem, appetite regulation, GLP-1 receptor agonists, Allen Mouse Brain Atlas
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Animals, Antibodies, Brain, Male, Neurons, In Situ Hybridization, Mice, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.